NM Bleehen

1.4k total citations
22 papers, 1.1k citations indexed

About

NM Bleehen is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, NM Bleehen has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in NM Bleehen's work include Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). NM Bleehen is often cited by papers focused on Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). NM Bleehen collaborates with scholars based in United Kingdom and United States. NM Bleehen's co-authors include SP Stenning, DJ Girling, RJ Stephens, David Machin, J G Reeve, Jie Xiong, Sally Stenning, V. Sundaresan, Peter Fayers and T.S. Maughan and has published in prestigious journals such as British Journal of Cancer, PubMed and UCL Discovery (University College London).

In The Last Decade

NM Bleehen

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
NM Bleehen United Kingdom 13 461 408 285 260 234 22 1.1k
Ole Nome Norway 19 306 0.7× 317 0.8× 273 1.0× 86 0.3× 109 0.5× 39 1.2k
Felipe Cardenal Spain 21 1.1k 2.4× 1.0k 2.5× 100 0.4× 493 1.9× 327 1.4× 41 1.8k
A. Y. Chang United States 17 494 1.1× 724 1.8× 59 0.2× 230 0.9× 106 0.5× 40 1.3k
Mark H. Leibenhaut United States 14 1.0k 2.3× 413 1.0× 282 1.0× 97 0.4× 60 0.3× 27 1.3k
Michael Xiang United States 16 295 0.6× 351 0.9× 102 0.4× 475 1.8× 65 0.3× 68 1.1k
H. Choy United States 25 1.5k 3.2× 973 2.4× 204 0.7× 157 0.6× 180 0.8× 108 2.0k
Anna Gregor United Kingdom 15 1.3k 2.8× 1.5k 3.8× 479 1.7× 279 1.1× 893 3.8× 27 2.2k
Fawn D. Vigneau United States 13 1.5k 3.2× 1.3k 3.1× 510 1.8× 209 0.8× 243 1.0× 21 2.1k
William Mietlowski United States 16 289 0.6× 500 1.2× 695 2.4× 347 1.3× 80 0.3× 32 1.8k
S.M. O'Reilly United Kingdom 14 294 0.6× 641 1.6× 293 1.0× 225 0.9× 75 0.3× 26 1.2k

Countries citing papers authored by NM Bleehen

Since Specialization
Citations

This map shows the geographic impact of NM Bleehen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NM Bleehen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NM Bleehen more than expected).

Fields of papers citing papers by NM Bleehen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NM Bleehen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NM Bleehen. The network helps show where NM Bleehen may publish in the future.

Co-authorship network of co-authors of NM Bleehen

This figure shows the co-authorship network connecting the top 25 collaborators of NM Bleehen. A scholar is included among the top collaborators of NM Bleehen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NM Bleehen. NM Bleehen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mead, G.M., NM Bleehen, A. Gregor, et al.. (1998). Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06.. UCL Discovery (University College London). 1 indexed citations
2.
Miles, Kenneth A., et al.. (1996). A simplified technique for measurement of blood-brain barrier permeability using CT: Preliminary results of the effect of RMP-7. UCL Discovery (University College London). 8 indexed citations
3.
Reeve, J G, et al.. (1996). Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. British Journal of Cancer. 73(10). 1193–1200. 80 indexed citations
4.
Bleehen, NM, DJ Girling, Penelope Hopwood, et al.. (1996). Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. British Journal of Cancer. 73(3). 406–413. 43 indexed citations
5.
Ward, R., et al.. (1995). Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients. British Journal of Cancer. 72(1). 198–205. 27 indexed citations
6.
Bleehen, NM, et al.. (1995). Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined. British Journal of Cancer. 71(6). 1175–1180. 25 indexed citations
7.
Bleehen, NM, A H Calvert, Siow Ming Lee, et al.. (1994). A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma. British Journal of Cancer. 70(4). 775–777.
8.
Bleehen, NM, DJ Girling, David Machin, & RJ Stephens. (1993). A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. British Journal of Cancer. 68(6). 1157–1166. 59 indexed citations
9.
10.
11.
Maughan, T.S., et al.. (1992). Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data. British Journal of Cancer. 66(3). 579–582. 6 indexed citations
12.
Bleehen, NM & SP Stenning. (1991). A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. British Journal of Cancer. 64(4). 769–774. 315 indexed citations
13.
Fayers, Peter, NM Bleehen, DJ Girling, & RJ Stephens. (1991). Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party. British Journal of Cancer. 64(2). 299–306. 57 indexed citations
14.
Sundaresan, V., et al.. (1991). Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. British Journal of Cancer. 64(2). 333–338. 74 indexed citations
15.
Bleehen, NM, DJ Girling, A. Gregor, et al.. (1991). A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. British Journal of Cancer. 64(4). 775–779. 10 indexed citations
16.
Bleehen, NM. (1990). Lung cancer – still a long road ahead. British Journal of Cancer. 61(4). 493–494. 12 indexed citations
17.
Reeve, J G, et al.. (1990). Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours. British Journal of Cancer. 61(5). 727–731. 44 indexed citations
18.
Kerr, D J, T.S. Maughan, ES Newlands, et al.. (1989). Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. British Journal of Cancer. 60(1). 104–106. 73 indexed citations
19.
Bleehen, NM, et al.. (1989). Radiotherapy in high grade gliomas. British Journal of Cancer. 60(5). 804–804. 1 indexed citations
20.
Smith, Peter J., et al.. (1988). Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells. British Journal of Cancer. 57(5). 445–450. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ole Nome Breakdown of academic impact, for papers by Felipe Cardenal Breakdown of academic impact, for papers by A. Y. Chang Breakdown of academic impact, for papers by Mark H. Leibenhaut Breakdown of academic impact, for papers by Michael Xiang Breakdown of academic impact, for papers by H. Choy Breakdown of academic impact, for papers by Anna Gregor Breakdown of academic impact, for papers by Fawn D. Vigneau Breakdown of academic impact, for papers by William Mietlowski Breakdown of academic impact, for papers by S.M. O'Reilly
Rankless by CCL
2026